Conditions

A new study has shown that for people with iron-deficiency anemia, elevated A1c’s may not reflect glycemic parameter.…

The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted overwhelmingly (20 to 2) in favor of approving the obesity drug Qnexa (Vivus, Inc.), a combination of phentermine and controlled-release topiramate. Qnexa could be the first prescription drug for obesity to reach the market since 1999.…

An FDA advisory committee’s endorsement of the anti-obesity drug Qnexa could re-energize the pharmaceutical industry after several years of disappointment in trying to develop anti-obesity drugs.…

In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people….

Researchers at Washington University School of Medicine in St. Louis have identified a potent regulator of sensitivity to insulin….

Hypertensive disorders in pregnancy and gestational diabetes are associated with a greater predicted risk of future cardiovascular disease.…

Decaf coffee was found to improve glucose energy metabolism in the brain in mouse studies.…

The 50-g glucose challenge test is an “acceptable” screening test for GDM but it can’t replace the OGTT.…

Vivus Inc said the FDA has asked the company to remove a contraindication in the proposed label of its obesity drug Qnexa, a move that could help it reach a broader patient population.…

The study findings indicate that medical professionals with normal BMI more frequently reported discussing weight loss with patients than overweight or obese medical professionals….